tirzepatide brand name mounjaro for Weight Loss FDA approves Eli Lilly's diabetes

For people with diabetes or prediabetes, this theoretical additive effect should be discussed with your prescribing physician before combining treatments

Data on other compounds such as DDP-4 and SGLT-2 inhibitors are limited

Japan is projected to record a 17.9% CAGR as treatment eligibility and structured health guidance keep clinical oversight central

Seek out a doctor, ideally one with experience in functional medicine, longevity, or peptide therapies

Semaglutide appears to exceed both of these benchmarks substantially, though direct head-to-head comparisons in the same trial are still needed

Our guide on why weight gain occurs on tirzepatide covers the most common reasons and solutions